Virginia Contract Research Organization Co., Ltd. (VCRO) professional team has successfully prepared and submitted a Phase I/IIa IND package in common technical document (CTD) format to the US FDA on 05/19/2014. The Phase I/IIa clinical trial of a botanical drug for metastatic colorectal cancer treatment has been successfully accepted by the US FDA on 06/18/2014. The accomplishment has opened a new page of pharmaceutical development in Taiwan.
Congratulations! An IND of botanical drug for a Phase I/IIa study of metastatic colorectal cancer was accepted by the USA FDA
Virginia Contract Research Organization Co., Ltd. (VCRO) professional team has successfully prepared and submitted a Phase I/IIa IND package in common technical document (CTD) format to the US FDA on 05/19/2014. The Phase I/IIa clinical trial of a botanical drug for metastatic colorectal cancer treatment has been successfully accepted by the US FDA on 06/18/2014.…